Antibiotic use for respiratory tract infections in nursing homes: a multicentre cross-sectional study

Read full text
Authors: Carl Llor, Rosa Morros, Jesús Mateos‐Nozal, Carlota Manuela Zárate Sáez, María N. Vaquero Pinto, Consuelo Rodríguez Jiménez, Carmen Sáez Béjar, Rosa Magallón Botaya, Priscila Matovelle, Alicia Navarro Sanmartín, Elena López Pérez, Ana García-Sangenís
+1 more Ramon Monfà
Cited by: 0
References: 40

Abstract

Introduction: To evaluate the use of antibiotic treatment for respiratory tract infections (RTIs) in nursing homes in Spain, assess whether they were indicated based on current guidelines, and identify predictors of both use and inappropriate use of antibiotics. Methods: Cross-sectional study carried out in 34 nursing homes in five areas in Spain. Nursing staff self-registered residents related to antibiotic use for RTIs in February-April 2023. Nursing staff recorded data on residents with RTIs, including demographics, symptoms, diagnoses, and antibiotic use. Logistic regression models were applied to identify predictors of antibiotic prescription and inappropriate use based on clinical guidelines. Results: Among 533 recorded RTI cases, the most common diagnoses were common cold (19.7%) and acute bronchitis (18.8%). Antibiotics were prescribed in 77.5% of cases, mainly for otitis media, tonsillitis, and pneumonia, with amoxicillin-clavulanate being the most frequent (34%). Of 328 prescriptions assessed, 63.1% were deemed unnecessary. Factors strongly associated with antibiotic use included confusion (odds ratio 4.72; p = 0.005), perceived demand for antibiotics (OR 3.83; p < 0.001), and fever (OR 3.27; p = 0.005), whereas rhinorrhea reduced the likelihood of prescription (OR 0.23; p < 0.001). Discussion: The findings reveal substantial overuse of antibiotics for RTIs in nursing homes and highlight the need for targeted interventions to promote guideline-based prescribing and reduce inappropriate use.

Fields of Study & Subjects

Antibiotic Use and Resistance Nosocomial Infections in ICU Pneumonia and Respiratory Infections

Publication details

Journal / source
Frontiers in Pharmacology
Volume
16
Pages
1721689–1721689
Publication date
5 January 2026
Language
EN